// App-Quantinova.ai

P2-16-31 : The differential impact of non-anthracycline treatment regimens on pathological complete response (pCR) rates by ER status after neoadjuvant single or dual HER2 targeted therapy (NACT): A single centre experience

Researchers

Presenter

  • Jessica Little

Principal Investigators

  • Samantha Forner

  • Van Sim

  • Russell Burcombe

  • Rema Jyothirmayi

  • Jennifer Louise Glendenning

Medical Centers

  • Maidstone and Tunbridge Wells NHS Trust, Maidstone, Kent, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved